Find therapies in clinical trials near you – page 173

Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

Study on the Effects of GLPG3667 for Adults with Dermatomyositis

Study on the Effects of GLPG3667 for Adults with Dermatomyositis

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure